biotech · Head and Neck Cancer · Head and Neck Squamous Cell Carcinoma · CUE
Cue Biopharma
Cue Biopharma is a biotech organization headquartered in Boston, USA. It trades on NYSE under ticker CUE. Primary therapeutic focus areas include Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal
Boston, USA HQ
2014 Founded
37 Employees
Public company Type
CUE · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2014
- Employees
- 37
- Programs
- 5
- Drugs
- 0
- Patents
- 30
CUE-101
Phase 2 · small molecule · Oropharyngeal Squamous Cell Carcinoma
CUE-101 for Oropharyngeal Squamous Cell Carcinoma is a Phase 2 program (small_molecule) at Cue Biopharma with 1 ClinicalTrials.gov record(s).
Internal code 202106015
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Cue Biopharma
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Oropharyngeal Squamous Cell Carcinoma
- Status
- active
- Trials
- 1